CYBERDYNE Inc. (CYBQY)
OTCMKTS · Delayed Price · Currency is USD
1.070
-0.120 (-10.08%)
At close: Dec 12, 2025
CYBERDYNE Market Cap
CYBERDYNE has a market cap or net worth of $267.88 million as of December 16, 2025. Its market cap has decreased by -3.04% in one year.
Market Cap
267.88M
Enterprise Value
243.06M
Revenue
28.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.07
Market Cap Chart
Since March 26, 2014, CYBERDYNE's market cap has decreased from 1.02B to 267.88M, a decrease of -73.69%. That is a compound annual growth rate of -10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 267.88M | 10.17% |
| Dec 30, 2024 | 243.15M | -27.53% |
| Dec 29, 2023 | 335.50M | -31.68% |
| Dec 30, 2022 | 491.04M | -25.76% |
| Dec 30, 2021 | 661.43M | -56.25% |
| Dec 30, 2020 | 1.51B | 34.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |